Investors Catching Stocks Express Scripts Holding Company(NASDAQ:ESRX): Portola Pharmaceuticals, Inc.(NASDAQ:PTLA)


Portola Pharmaceuticals, Inc. (PTLA) will report its next earnings on May 11 AMC. The company reported the earnings of $-0.88/Share in the last quarter where the estimated EPS by analysts was $-0.8/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -10%.

Many analysts are providing their Estimated Earnings analysis for Portola Pharmaceuticals, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.7/share. These analysts have also projected a Low Estimate of $-0.82/share and a High Estimate of $-0.51/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Portola Pharmaceuticals, Inc. as 24.09 Million. According to these analysts, the Low Revenue Estimate for Portola Pharmaceuticals, Inc. is 21.3 Million and the High Revenue Estimate is 29.28 Million. The company had Year Ago Sales of 25.54 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for PTLA to be 10.9%. They are projecting Next Quarter growth of -26.42%. For the next 5 years, Portola Pharmaceuticals, Inc. is expecting Growth of 22.05% per annum, whereas in the past 5 years the growth was 29.06% per annum.

Some buy side analysts are also providing their Analysis on Portola Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.32 and Average Volume (3 months) is 4.29 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -55.3%. The Return on Equity (ROE) value stands at -270.9%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Portola Pharmaceuticals, Inc. currently shows a Weekly Performance of 0.17%, where Monthly Performance is 152.26%, Quarterly performance is 81.69%, 6 Months performance is -38.16% and yearly performance percentage is -35.96%. Year to Date performance value (YTD perf) value is -25.21%. The Stock currently has a Weekly Volatility of 0.62% and Monthly Volatility of 1.45%.